# Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection

> **NCT06784973** · PHASE2 · TERMINATED · sponsor: **Gilead Sciences** · enrollment: 4 (actual)

## Conditions studied

- RSV Infection

## Interventions

- **DRUG:** Obeldesivir
- **DRUG:** Obeldesivir Placebo

## Key facts

- **NCT ID:** NCT06784973
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2025-03-05
- **Primary completion:** 2025-04-16
- **Final completion:** 2025-04-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Study was terminated by Sponsor; the decision was not due to any safety findings.
- **Last updated:** 2025-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06784973

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06784973, "Study of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT06784973. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*